L
Lingli Tu
Researcher at Sichuan University
Publications - 9
Citations - 104
Lingli Tu is an academic researcher from Sichuan University. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 3, co-authored 6 publications receiving 84 citations.
Papers
More filters
Journal ArticleDOI
Endostar, a recombined humanized endostatin, enhances the radioresponse for human nasopharyngeal carcinoma and human lung adenocarcinoma xenografts in mice.
TL;DR: It is concluded that endostar significantly sensitized the function of radiation in antitumor and antiangiogenesis in human nasopharyngeal carcinoma and human lung adenocarcinoma xenografts by increasing the apoptosis of the endothelial cell and tumor cell, improving the hypoxia of the tumorcell, and changing the proangiogenic factors.
Journal ArticleDOI
Paclitaxel and cisplatin combined with intensity-modulated radiotherapy for upper esophageal carcinoma
Lingli Tu,Lan Sun,Yong Xu,Yongsheng Wang,Lin Zhou,Yongmei Liu,Jiang Zhu,Feng Peng,Yuquan Wei,Youling Gong +9 more
TL;DR: For those patients with upper esophageal carcinoma, IMRT combined with concurrent TP regimen chemotherapy was an effective treatment, however, more attention should be paid to the occurrence of perforation and hemorrhea.
Journal ArticleDOI
Assessment of a passive immunity mouse model to quantitatively analyze the impact of neutralizing antibodies on adeno-associated virus-mediated gene transfer
TL;DR: The findings indicated that the in vivo NAb assay is superior to the in vitro assay for detecting low NAb titers, and can mediate neutralization in vivo.
Journal ArticleDOI
Paclitaxel and Cisplatin Combined with Intensity-Modulated Radiotherapy for Upper Esophageal Carcinoma
Lingli Tu,Lan Sun,Youling Gong,Y. Liu,Lin Zhou,Xiaojuan Zhou,Yong Xu,Jing Wang,Mei Hou,Yiping Lu +9 more
TL;DR: For those patients with upper esophageal carcinoma, IMRT combined with concurrent TP regimen chemotherapy was an effective treatment, however, special attention should be paid to the occurrence of perforation and hemorrhea.
Journal ArticleDOI
Postoperative radiotherapy for residual tumor of primary mediastinal carcinoid teratoma
TL;DR: In conclusion, adjuvant radiotherapy with 50 Gy is an effective approach for residual tumor of mediastinal carcinoid teratoma of a 36-year-old woman with dry cough.